Tuesday, June 24, 2025

Latest:

Study reveals rare gene variants contributing to systemic sclerosis risk
LED light therapy: How does it work on your skin?
From the classroom to the capitol: Medical students in action
Study reveals heterogeneity of bone metastases across different and same cancer types
What is testosterone therapy?

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Acute Lymphoblastic Leukemia

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019 Acute Lymphoblastic Leukemia, ALL, carbon metabolism, metabolome, Pediatric Cancer, prognosis, Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019 Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs: a closer look at metastatic medulloblastoma